Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-24

Clinical Trial Update: Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring genetic variants that influence microglial activation in Alzheimer's disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Alzheimer Disease | Phase 2 | Status: RECRUITING